EGFR Tyrosine Kinase Inhibitors Prolong Overall Survival in EGFR Mutated Non-Small-Cell Lung Cancer Patients with Postsurgical Recurrence . J. Can. Res. Updates. 2012;1(1): 102-107. doi:10.6000/1929-2279.2012.01.01.15